Enrolling people of color to evaluate a practice intervention: lessons from the shared decision-making for atrial fibrillation (SDM4AFib) trial

Angela Sivly, Haeshik S Gorr, Derek Gravholt, Megan E Branda, Mark Linzer, Peter Noseworthy, Ian Hargraves, Marleen Kunneman, Chyke A Doubeni, Takeki Suzuki, Juan P Brito, Elizabeth A Jackson, Bruce Burnett, Mike Wambua, Victor M Montori, Shared Decision-Making for Atrial Fibrillation (SDM4AFib) Trial Investigators, Victor M Montori, Megan E Branda, Juan P Brito, Marleen Kunneman, Ian Hargraves, Angela Sivly, Kirsten Fleming, Bruce Burnett, Mark Linzer, Haeshik Gorr, Elizabeth A Jackson, Erik Hess, Takeki Suzuki, James Iv Hamilton, Peter A Noseworthy, Alexander Haffke, Jule Muegge, Sara Poplau, Benjamin Simpson, Miamoua Vang, Mike Wambua, Joel Anderson, Emma Behnken, Fernanda Bellolio, Renee Cabalka, Michael Ferrara, Rachel Giblon, Jonathan Inselman, Annie LeBlanc, Alexander Lee, Victor Montori, Marc Olive, Paige Organick, Nilay Shah, Gabriela Spencer-Bonilla, Amy Stier, Anjali Thota, Henry Ting, Derek Vanmeter, Claudia Zeballos-Palacios, Carol Abullarade, Lisa Harvey, Shelly Keune, Timothy Smith, Shannon Stephens, Bryan Barksdale, Theresa Hickey, Roma Peters, Memrie Price, Connie Watson, Douglas Wolfe, Gordon Guyatt, Brian Haynes, George Tomlinson, Paul Daniels, Bernard Gersh, Thomas Jaeger, Robert McBane, Angela Sivly, Haeshik S Gorr, Derek Gravholt, Megan E Branda, Mark Linzer, Peter Noseworthy, Ian Hargraves, Marleen Kunneman, Chyke A Doubeni, Takeki Suzuki, Juan P Brito, Elizabeth A Jackson, Bruce Burnett, Mike Wambua, Victor M Montori, Shared Decision-Making for Atrial Fibrillation (SDM4AFib) Trial Investigators, Victor M Montori, Megan E Branda, Juan P Brito, Marleen Kunneman, Ian Hargraves, Angela Sivly, Kirsten Fleming, Bruce Burnett, Mark Linzer, Haeshik Gorr, Elizabeth A Jackson, Erik Hess, Takeki Suzuki, James Iv Hamilton, Peter A Noseworthy, Alexander Haffke, Jule Muegge, Sara Poplau, Benjamin Simpson, Miamoua Vang, Mike Wambua, Joel Anderson, Emma Behnken, Fernanda Bellolio, Renee Cabalka, Michael Ferrara, Rachel Giblon, Jonathan Inselman, Annie LeBlanc, Alexander Lee, Victor Montori, Marc Olive, Paige Organick, Nilay Shah, Gabriela Spencer-Bonilla, Amy Stier, Anjali Thota, Henry Ting, Derek Vanmeter, Claudia Zeballos-Palacios, Carol Abullarade, Lisa Harvey, Shelly Keune, Timothy Smith, Shannon Stephens, Bryan Barksdale, Theresa Hickey, Roma Peters, Memrie Price, Connie Watson, Douglas Wolfe, Gordon Guyatt, Brian Haynes, George Tomlinson, Paul Daniels, Bernard Gersh, Thomas Jaeger, Robert McBane

Abstract

Background: Trial recruitment of Black, indigenous, and people of color (BIPOC) is key for interventions that interact with socioeconomic factors and cultural norms, preferences, and values. We report on our experience enrolling BIPOC participants into a multicenter trial of a shared decision-making intervention about anticoagulation to prevent strokes, in patients with atrial fibrillation (AF).

Methods: We enrolled patients with AF and their clinicians in 5 healthcare systems (three academic medical centers, an urban/suburban community medical center, and a safety-net inner-city medical center) located in three states (Minnesota, Alabama, and Mississippi) in the United States. Clinical encounters were randomized to usual care with or without a shared decision-making tool about anticoagulation.

Analysis: We analyzed BIPOC patient enrollment by site, categorized reasons for non-enrollment, and examined how enrollment of BIPOC patients was promoted across sites.

Results: Of 2247 patients assessed, 922 were enrolled of which 147 (16%) were BIPOC patients. Eligible Black participants were significantly less likely (p < .001) to enroll (102, 11%) than trial-eligible White participants (185, 15%). The enrollment rate of BIPOC patients varied by site. The inclusion and prioritization of clinical practices that care for more BIPOC patients contributed to a higher enrollment rate into the trial. Specific efforts to reach BIPOC clinic attendees and prioritize their enrollment had lower yield.

Conclusions: Best practices to optimize the enrollment of BIPOC participants into trials that examined complex and culturally sensitive interventions remain to be developed. This study suggests a high yield from enrolling BIPOC patients from practices that prioritize their care.

Trial registration: ClinicalTrials.gov (NCT02905032).

Keywords: BIPOC; Complex interventions; Diversity; Enrollment; Equity; Minorities; Practice-based trials; Shared decision-making.

Conflict of interest statement

The authors do not have any competing interests relevant to the content of this report.

© 2022. The Author(s).

Figures

Fig. 1
Fig. 1
Proportion of BIPOC participants enrolled, by participating trial site. Proportion of Black, Indigenous and people of color (BIPOC) patients by enrollment status and main reasons for non-enrollment. Total enrollment of BIPOC patients was 147, 10 from University of Alabama at Birmingham (AL), 60 from Hennepin Healthcare (HCMC), 6 from Mayo Clinic, 30 from University of Mississippi (MS), and 41 from Park Nicollet (PN)
Fig. 2
Fig. 2
Enrollment over time. The black line represents the cumulative enrollment of Black, Indigenous and people of color (BIPOC) patients. The arrows depict the start of enrollment at participating health systems: (1) Mayo Clinic (first quarter (Q1), 2017); (2) Hennepin Healthcare and Park Nicollet (Q2, 2017); and (3) University of Alabama at Birmingham and University of Mississippi (Q4, 2018)

References

    1. Campbell M, Fitzpatrick R, Haines A, Kinmonth AL, Sandercock P, Spiegelhalter D, et al. Framework for design and evaluation of complex interventions to improve health. BMJ. 2000;321(7262):694–696. doi: 10.1136/bmj.321.7262.694.
    1. Stafford M, Soljak M, Pledge V, Mindell J. Socio-economic differences in the health-related quality of life impact of cardiovascular conditions. Eur J Public Health. 2012;22(3):301–305. doi: 10.1093/eurpub/ckr007.
    1. Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. GRADE guidelines: 8. Rating the quality of evidence--indirectness. J Clin Epidemiol. 2011;64(12):1303–1310. doi: 10.1016/j.jclinepi.2011.04.014.
    1. Mody P, Gupta A, Bikdeli B, Lampropulos JF, Dharmarajan K. Most important articles on cardiovascular disease among racial and ethnic minorities. Circ Cardiovasc Qual Outcomes. 2012;5(4):e33–e41. doi: 10.1161/CIRCOUTCOMES.112.967638.
    1. Bailey ZD, Feldman JM, Bassett MT. How structural racism works — racist policies as a root cause of U.S. racial health inequities. N Engl J Med. 2020;384(8):768–773. doi: 10.1056/NEJMms2025396.
    1. George S, Duran N, Norris K. A systematic review of barriers and facilitators to minority research participation among African Americans, Latinos, Asian Americans, and Pacific Islanders. Am J Public Health. 2014;104(2):e16–e31. doi: 10.2105/AJPH.2013.301706.
    1. Mbuagbaw L, Aves T, Shea B, Jull J, Welch V, Taljaard M, et al. Considerations and guidance in designing equity-relevant clinical trials. Int J Equity Health. 2017;16(1):93. doi: 10.1186/s12939-017-0591-1.
    1. Kunneman M, Branda ME, Noseworthy PA, Linzer M, Burnett B, Dick S, et al. Shared decision making for stroke prevention in atrial fibrillation: study protocol for a randomized controlled trial. Trials. 2017;18(1):443. doi: 10.1186/s13063-017-2178-y.
    1. Kunneman M, Branda ME, Hargraves IG, Sivly AL, Lee AT, Gorr H, et al. Assessment of Shared Decision-making for Stroke Prevention in Patients With Atrial Fibrillation: A Randomized Clinical Trial. JAMA Intern Med. 2020;180(9):1215–1224. doi: 10.1001/jamainternmed.2020.2908.
    1. Minnesota Compass. Cultural communities 2021. Available from: .
    1. Chen ML, Parikh NS, Merkler AE, Kleindorfer DO, Bhave PD, Levitan EB, et al. Risk of atrial fibrillation in black versus white Medicare beneficiaries with implanted cardiac devices. J Am Heart Assoc. 2019;8(4):e010661. doi: 10.1161/JAHA.118.010661.
    1. Loehr LR, Soliman EZ, Poon AK, Couper D, Chen LY, Mosley TH, et al. The prevalence of atrial fibrillation on 48-hour ambulatory electrocardiography in African Americans compared to Whites: The Atherosclerosis Risk in Communities (ARIC) study. Am Heart J. 2019;216:1–8. doi: 10.1016/j.ahj.2019.06.017.
    1. Wieland ML, Njeru JW, Alahdab F, Doubeni CA, Sia IG. Community-engaged approaches for minority recruitment into clinical research: a scoping review of the literature. Mayo Clin Proc. 2021;96(3):733–743. doi: 10.1016/j.mayocp.2020.03.028.

Source: PubMed

3
S'abonner